ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients – ViroPharma Incorporated (Nasdaq: VPHM) announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint.
Marijuana use linked to increased risk of testicular cancer. Risk appears to be elevated particularly among frequent and/or long-term users of marijuana. – Frequent and/or long-term marijuana use may significantly increase a man’s risk of developing the most aggressive type of testicular cancer, according to a study by researchers at Fred Hutchinson Cancer Research Center.
Animal eggs not suitable substitutes to produce stem cells – Since the cloning of Dolly the Sheep over a decade ago, somatic cell nuclear transfer (SCNT) has been considered a promising way to generate human, patient-specific stem cells for therapeutic applications.
Geron Receives FDA Clearance to Begin World’s First Human Clinical Trial of Embryonic Stem Cell-Based Therapy. Geron to Study GRNOPC1 in Patients with Acute Spinal Cord Injury. – Geron Corporation (Nasdaq: GERN) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company’s Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
Olivia Newton-John visits UK’s Addenbrooke?s Hospital to support breast cancer appeal – Grease star and cancer campaigner Olivia Newton-John is returning to her Cambridge roots on Wednesday 14 January when she visits Addenbrooke’s Hospital to find out about the latest research into breast cancer.
All NIH human embryonic stem cell registry lines now deposited at NSCB – The U.S. National Stem Cell Bank (NSCB) has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden. With the addition of the new lines, the National Stem Cell Bank now has received all 21 cell lines from the six providers listed on the National Institutes of Health (NIH) federal registry.
Scientists call up stem cell troops to repair the body using new drug combinations – Scientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal Cell Stem Cell.
Health Minister invites diaspora to join in developing healthcare – Indian Health Minister Dr. Anbumani Ramadoss has called for public-private partnership in health sector to meet the gap between supply and demand.
Salk researchers develop novel brain cancer glioblastoma mouse model. – Researchers at the Salk Institute for Biological Studies have developed a versatile mouse model of glioblastoma-the most common and deadly brain cancer in humans-that closely resembles the development and progression of human brain tumors that arise naturally.
Scientists can now differentiate between healthy cells and cancer cells and normal stem cells. – One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process.
USC researchers derive first embryonic stem cells from rats. Finding represents major breakthrough for biomedical research. – Researchers at the University of Southern California (USC) have, for the first time in history, derived authentic embryonic stem (ES) cells from rats. This breakthrough finding will enable scientists to create far more effective animal models for the study of a range of human diseases.
US researchers watched genetic diseases unfolding in the laboratory after finding a way to make large numbers of affected cells. – When neurons started dying in Clive Svendsen’s lab dishes, he couldn’t have been more pleased. The dying cells ? the same type lost in patients with the devastating neurological disease spinal muscular atrophy ? confirmed that the University of Wisconsin-Madison stem cell biologist had recreated the hallmarks of a genetic disorder in the lab, using stem cells derived from a patient.
